Researchers have significantly improved the knowledge of the mediators of obesity-related diseases and described a number of various enzymes taking part in different pathways of ceramide metabolism, such as SPT, CerS family or GPATs, which turn to be potential targets to manipulate ceramide generation. This evidence concerns the gene AGXT and obesity disorder.